99 related articles for article (PubMed ID: 5958855)
1. Effects of some biogenic amines on the blood pressure of pargyline-treated rabbits.
Airaksinen MM; Mustala O; Torsti P
Ann Med Exp Biol Fenn; 1966; 44(3):376-81. PubMed ID: 5958855
[No Abstract] [Full Text] [Related]
2. [Unsucessful inhibition of pressor effects of sympathetic post-ganglionic stimulation fibers due to an inhibitor of MAO].
Brotzu G; Milani R; Gessa GL
Boll Soc Ital Biol Sper; 1967 Oct; 43(19):1272-5. PubMed ID: 5589840
[No Abstract] [Full Text] [Related]
3. [Mechanism of action of adrenaline and some other biogenic amines on gamma-amylase activity of rat liver and heart muscle].
Orlova VS; Siniukhin VN; Popova IA; Gorkin VZ; Rozenfel'd EL
Biokhimiia; 1971; 36(3):555-61. PubMed ID: 5132486
[No Abstract] [Full Text] [Related]
4. [Selective inhibition by pargyline and phenelzine of oxidation of biogenic amines in vivo].
Romanova LA; Gorkin VZ
Farmakol Toksikol; 1969; 32(6):667-9. PubMed ID: 5381595
[No Abstract] [Full Text] [Related]
5. Proceedings: Influence of MAO-inhibitors on the intestinal absorption of biogenic amines.
Huebers H; Huebers E; Huebers U; Rummel W
Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R36. PubMed ID: 4276566
[No Abstract] [Full Text] [Related]
6. [Cardiovascular effects of (+)- and (-)-tranylcypromine compared to other monoamine oxidase inhibitors in animal studies (author's transl)].
Dénes B; Greeff K; Tawfik H
Arzneimittelforschung; 1982; 32(3):201-7. PubMed ID: 6805481
[TBL] [Abstract][Full Text] [Related]
7. [Relationship between the chemical structure and uterine action of aralkylhydrazines and aralkylamines].
Kudrin AN; Koroza GS
Farmakol Toksikol; 1967; 30(6):718-22. PubMed ID: 5598445
[No Abstract] [Full Text] [Related]
8. Interaction between some cheeses and monoamine oxydase inhibitors.
Kayaalp SO; Kaymakçalan S; Ozer A
Arzneimittelforschung; 1968 Sep; 18(9):1195-8. PubMed ID: 5756049
[No Abstract] [Full Text] [Related]
9. [Preliminary tests of the action of an MAO inhibitor (Pargyline) on iris motility].
Balacco-Gabrieli C
Boll Soc Ital Biol Sper; 1971 Jan; 47(2):33-5. PubMed ID: 5088815
[No Abstract] [Full Text] [Related]
10. [Effect of monoamine oxidase inhibitors on iris motility].
Balacco-Gabrieli C; Scorcia G
Minerva Oftalmol; 1971; 13(4):117-24. PubMed ID: 5145165
[No Abstract] [Full Text] [Related]
11. D-amphetamine-induced hydrogen peroxide production in skeletal muscle is modulated by monoamine oxidase inhibition.
Duarte JA; Carvalho F; Fernandes E; Remião F; Bastos ML; Magalhães J; Appell HJ
Int J Sports Med; 2004 Aug; 25(6):446-9. PubMed ID: 15346233
[TBL] [Abstract][Full Text] [Related]
12. Effects of some monoamine oxidase inhibitors on the refractory period of isolated rabbit auricles.
Bose D
Indian J Physiol Pharmacol; 1968 Jan; 12(1):63-4. PubMed ID: 5673672
[No Abstract] [Full Text] [Related]
13. [Effect of monoamine oxidase inhibitors of various chemical nature on some indices of carbohydrate metabolism in the rabbit brain].
Musialkovskaia AA
Ukr Biokhim Zh; 1967; 39(2):119-24. PubMed ID: 5603054
[No Abstract] [Full Text] [Related]
14. Differential development, inhibition, and recovery of monoamine oxidase in various parts of the rat heart.
Horita A
Res Commun Chem Pathol Pharmacol; 1970 Nov; 1(6):713-20. PubMed ID: 5524271
[No Abstract] [Full Text] [Related]
15. Synthesis and pharmacology of a pargyline analog, N-3-(1-butynyl)-benzylamine.
Siuda JF; Cihonski C; Sofia RD; Buckley JP
J Pharm Sci; 1973 Feb; 62(2):331-2. PubMed ID: 4686418
[No Abstract] [Full Text] [Related]
16. PS-2747: a new antidepressant agent.
Plotnikoff N; Will F; Evans A; Meekma P
Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):330-42. PubMed ID: 4622667
[No Abstract] [Full Text] [Related]
17. Evidence for inhibition of monoamine oxidase in vivo in rat brain by 7,8-dichloro-1,2,3,4-tetrahydroisoquinoline.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):519-22. PubMed ID: 6856953
[TBL] [Abstract][Full Text] [Related]
18. Allenic amines: a new class of nonhydrazine MAO inhibitors.
Halliday RP; Davis CS; Heotis JP; Pals DT; Watson EJ; Bickerton RK
J Pharm Sci; 1968 Mar; 57(3):430-3. PubMed ID: 5655581
[No Abstract] [Full Text] [Related]
19. Effect of monoamine oxidase (MAO) inhibition upon the N, P and LN potentials of the rabbit superior cervical ganglia.
Henderson G; Blakeley AG
Br J Pharmacol; 1971 Oct; 43(2):436P. PubMed ID: 4333807
[No Abstract] [Full Text] [Related]
20. Phenylisopropylmethylpropinylamine (E-250), a new spectrum psychic energizer.
Knoll J; Ecseri Z; Kelemen K; Nievel J; Knoll B
Arch Int Pharmacodyn Ther; 1965 May; 155(1):154-64. PubMed ID: 4378644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
